O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases
Guillermo Barturen(Universidad de Granada), Fernanda Genre(Marqués de Valdecilla University Hospital), Antonio López‐Berrio(Andalusian School of Public Health), Ralf Lesche(Howard Hughes Medical Institute), Nancy Azevedo(Centro Hospitalar do Porto), Zuzanna Makowska(University Hospital of Basel), Elena Trombetta(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Elena Carnero‐Montoro(Universitat Pompeu Fabra), Jordi Martorell‐Marugán(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Carlos Vasconcelos(Hospital de Santo António), Sepideh Babaei(Bayer (Germany)), Ana Campar(Centro Hospitalar do Porto), Concepción Marañón(Karolinska University Hospital), Marialbert Acosta‐Herrera(Instituto de Investigación Biosanitaria de Granada), Francesc Català‐Moll(IrsiCaixa), Esmeralda Neves(Universidade do Porto), Javier Rodríguez‐Ubreva(Josep Carreras Leukaemia Research Institute), Anne Buttgereit(Bayer (Germany)), Mariana Brandão(Centro Hospitalar do Porto), Tânia Gomes Anjos(Universidad de Granada), Sikander Hayat(Universitätsklinikum Aachen), Gaia Montanelli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Rocío Aguilar‐Quesada(Instituto de Investigación Biosanitaria de Granada), María Jazmín Abraham‐Juárez(University of California, Santa Cruz), Francisco Javier Garrancho(Andalusian School of Public Health), María P. Hernández-Fuentes(King's College London), António Marinho(Centro Hospitalar do Porto), Barbara Vigone(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Héctor Navarro‐Linares(Andalusian School of Public Health), Tania F. Rowley(UCB Pharma (United Kingdom)), Jorge Kageyama(Max Planck Institute for Developmental Biology), Fátima Farinha(Centro Hospitalar do Porto), Christophe Jamin(Inserm), Antonio García-Gómez(Institut d'Investigació Biomédica de Bellvitge), Raquel Faria(CUF Porto Hospital), Isabel Almeida(Centro Hospitalar do Porto), Pedro Carmona‐Sáez(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Manuel Martínez‐Bueno(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Tianlu Li(Institut d'Investigació Biomédica de Bellvitge), Daniel Toro‐Domínguez(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Ricardo Blanco(Universidad de Cantabria), Manuel Rodríguez Maresca(Andalusian School of Public Health), Joerg Mueller(Bayer (Germany)), Nieves Varela(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Ana Tavares(Centro Hospitalar do Porto), Ian N.H. White(UCB Pharma (United Kingdom)), Alfonso Corrales Martínez(Marqués de Valdecilla University Hospital), Martin Kerick(Max Planck Institute for Molecular Genetics), Damiana Álvarez‐Errico(Institut Municipal d'Assistència Sanitària), Lucas Le Lann(Inserm)
Cited by 3
Related Papers
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Spatial multi-omic map of human myocardial infarction
|Nature|2022|692